INS and obesity disorder: In addition to its anti-adipogenic effects, ASA also reduces the obesity-induced expression of inflammatory cytokines (IL-6, TNFα, and MCP-1) and adhesion molecules (ICAM-I and VCAM-I) while enhancing insulin sensitivity in high-fat diet-induced obese mice [39].